vs
Side-by-side financial comparison of AerSale Corp (ASLE) and BridgeBio Pharma, Inc. (BBIO). Click either name above to swap in a different company.
BridgeBio Pharma, Inc. is the larger business by last-quarter revenue ($154.2M vs $90.9M, roughly 1.7× AerSale Corp). AerSale Corp runs the higher net margin — 5.9% vs -126.2%, a 132.2% gap on every dollar of revenue. On growth, BridgeBio Pharma, Inc. posted the faster year-over-year revenue change (2521.2% vs -4.0%). AerSale Corp produced more free cash flow last quarter ($9.8M vs $-56.5M).
AerSale, Inc. is a Doral, Florida-based global supplier of aftermarket commercial jet aircraft, engines, used materials, and aeronautical engineering services to passenger and cargo airlines, government, multinational original equipment manufacturers, and independent MROs. AerSale is a member of the Aircraft Fleet Recycling Association.
Brent Saunders is an American biopharma executive and entrepreneur who is the chairman and CEO of the health company Bausch & Lomb. He helped lead various mergers and acquisitions, including the mergers between Merck and Schering-Plough, the acquisition of Bausch + Lomb by Valeant Pharmaceuticals, and the $63 billion acquisition of Allergan by Abbvie. He founded the special-purpose acquisition company (SPAC) Vesper Healthcare Acquisition. Saunders is also executive chairman of medical aesthet...
ASLE vs BBIO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $90.9M | $154.2M |
| Net Profit | $5.4M | $-194.6M |
| Gross Margin | 34.1% | 94.7% |
| Operating Margin | 7.8% | -90.5% |
| Net Margin | 5.9% | -126.2% |
| Revenue YoY | -4.0% | 2521.2% |
| Net Profit YoY | 99.7% | 27.2% |
| EPS (diluted) | $0.10 | $-1.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $90.9M | $154.2M | ||
| Q3 25 | $71.2M | $120.7M | ||
| Q2 25 | $107.4M | $110.6M | ||
| Q1 25 | $65.8M | $116.6M | ||
| Q4 24 | $94.7M | — | ||
| Q3 24 | $82.7M | — | ||
| Q2 24 | $77.1M | — | ||
| Q1 24 | $90.5M | $211.1M |
| Q4 25 | $5.4M | $-194.6M | ||
| Q3 25 | $-120.0K | $-184.9M | ||
| Q2 25 | $8.6M | $-183.8M | ||
| Q1 25 | $-5.3M | $-169.6M | ||
| Q4 24 | $2.7M | — | ||
| Q3 24 | $509.0K | — | ||
| Q2 24 | $-3.6M | — | ||
| Q1 24 | $6.3M | $-36.2M |
| Q4 25 | 34.1% | 94.7% | ||
| Q3 25 | 30.2% | 94.6% | ||
| Q2 25 | 32.9% | 96.7% | ||
| Q1 25 | 27.3% | 97.7% | ||
| Q4 24 | 31.4% | — | ||
| Q3 24 | 28.6% | — | ||
| Q2 24 | 28.2% | — | ||
| Q1 24 | 31.8% | 99.7% |
| Q4 25 | 7.8% | -90.5% | ||
| Q3 25 | 4.0% | -120.3% | ||
| Q2 25 | 11.7% | -121.4% | ||
| Q1 25 | -10.1% | -89.5% | ||
| Q4 24 | 5.2% | — | ||
| Q3 24 | 2.4% | — | ||
| Q2 24 | -2.4% | — | ||
| Q1 24 | 5.2% | 0.2% |
| Q4 25 | 5.9% | -126.2% | ||
| Q3 25 | -0.2% | -153.2% | ||
| Q2 25 | 8.0% | -166.2% | ||
| Q1 25 | -8.0% | -145.4% | ||
| Q4 24 | 2.9% | — | ||
| Q3 24 | 0.6% | — | ||
| Q2 24 | -4.7% | — | ||
| Q1 24 | 6.9% | -17.1% |
| Q4 25 | $0.10 | $-1.00 | ||
| Q3 25 | $0.00 | $-0.95 | ||
| Q2 25 | $0.18 | $-0.95 | ||
| Q1 25 | $-0.10 | $-0.88 | ||
| Q4 24 | $0.05 | — | ||
| Q3 24 | $0.01 | — | ||
| Q2 24 | $-0.07 | — | ||
| Q1 24 | $0.12 | $-0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.4M | $570.1M |
| Total DebtLower is stronger | $1.3M | $2.0B |
| Stockholders' EquityBook value | $424.4M | $-2.1B |
| Total Assets | $640.5M | $936.0M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.4M | $570.1M | ||
| Q3 25 | $5.3M | $643.0M | ||
| Q2 25 | $5.7M | $756.9M | ||
| Q1 25 | $4.7M | $540.6M | ||
| Q4 24 | $4.7M | — | ||
| Q3 24 | $9.8M | — | ||
| Q2 24 | $4.3M | — | ||
| Q1 24 | $2.6M | $519.7M |
| Q4 25 | $1.3M | $2.0B | ||
| Q3 25 | $1.5M | $2.0B | ||
| Q2 25 | $907.0K | — | ||
| Q1 25 | $1.1M | — | ||
| Q4 24 | $1.2M | — | ||
| Q3 24 | $376.0K | — | ||
| Q2 24 | $522.0K | — | ||
| Q1 24 | $3.5M | — |
| Q4 25 | $424.4M | $-2.1B | ||
| Q3 25 | $417.1M | $-1.9B | ||
| Q2 25 | $415.9M | $-1.8B | ||
| Q1 25 | $406.5M | $-1.6B | ||
| Q4 24 | $455.6M | — | ||
| Q3 24 | $451.5M | — | ||
| Q2 24 | $449.8M | — | ||
| Q1 24 | $452.0M | $-1.0B |
| Q4 25 | $640.5M | $936.0M | ||
| Q3 25 | $646.3M | $998.3M | ||
| Q2 25 | $646.7M | $1.1B | ||
| Q1 25 | $646.1M | $881.6M | ||
| Q4 24 | $604.7M | — | ||
| Q3 24 | $601.5M | — | ||
| Q2 24 | $598.7M | — | ||
| Q1 24 | $571.7M | $849.3M |
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.01× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $11.4M | $-56.4M |
| Free Cash FlowOCF − Capex | $9.8M | $-56.5M |
| FCF MarginFCF / Revenue | 10.8% | -36.6% |
| Capex IntensityCapex / Revenue | 1.7% | 0.0% |
| Cash ConversionOCF / Net Profit | 2.11× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-29.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.4M | $-56.4M | ||
| Q3 25 | $-8.9M | $-109.6M | ||
| Q2 25 | $19.8M | $-80.7M | ||
| Q1 25 | $-45.2M | $-199.2M | ||
| Q4 24 | $37.5M | — | ||
| Q3 24 | $10.4M | — | ||
| Q2 24 | $-15.3M | — | ||
| Q1 24 | $-21.5M | $-219.5M |
| Q4 25 | $9.8M | $-56.5M | ||
| Q3 25 | $-9.8M | $-110.0M | ||
| Q2 25 | $18.6M | $-81.3M | ||
| Q1 25 | $-47.6M | — | ||
| Q4 24 | $32.3M | — | ||
| Q3 24 | $8.9M | — | ||
| Q2 24 | $-18.9M | — | ||
| Q1 24 | $-25.0M | $-220.2M |
| Q4 25 | 10.8% | -36.6% | ||
| Q3 25 | -13.8% | -91.2% | ||
| Q2 25 | 17.3% | -73.5% | ||
| Q1 25 | -72.4% | — | ||
| Q4 24 | 34.0% | — | ||
| Q3 24 | 10.7% | — | ||
| Q2 24 | -24.6% | — | ||
| Q1 24 | -27.7% | -104.3% |
| Q4 25 | 1.7% | 0.0% | ||
| Q3 25 | 1.3% | 0.4% | ||
| Q2 25 | 1.1% | 0.5% | ||
| Q1 25 | 3.7% | 0.0% | ||
| Q4 24 | 5.6% | — | ||
| Q3 24 | 1.9% | — | ||
| Q2 24 | 4.7% | — | ||
| Q1 24 | 3.9% | 0.3% |
| Q4 25 | 2.11× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 2.31× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 13.89× | — | ||
| Q3 24 | 20.52× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -3.42× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASLE
| Products | $57.8M | 64% |
| Maintenance | $23.2M | 26% |
| Leasing Arrangements | $9.9M | 11% |
BBIO
Segment breakdown not available.
